Jennifer Lin

3.5k total citations · 1 hit paper
43 papers, 1.6k citations indexed

About

Jennifer Lin is a scholar working on Oncology, Genetics and Molecular Biology. According to data from OpenAlex, Jennifer Lin has authored 43 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 11 papers in Genetics and 9 papers in Molecular Biology. Recurrent topics in Jennifer Lin's work include Chronic Lymphocytic Leukemia Research (10 papers), Lymphoma Diagnosis and Treatment (6 papers) and Lipoproteins and Cardiovascular Health (4 papers). Jennifer Lin is often cited by papers focused on Chronic Lymphocytic Leukemia Research (10 papers), Lymphoma Diagnosis and Treatment (6 papers) and Lipoproteins and Cardiovascular Health (4 papers). Jennifer Lin collaborates with scholars based in United States, France and Australia. Jennifer Lin's co-authors include JoAnn E. Manson, Shari S. Bassuk, Michelle A. Albert, I‐Min Lee, David Gordon, Eleanor Danielson, Jean MacFadyen, Julie E. Buring, Elaine Zaharris and Nancy R. Cook and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Molecular and Cellular Biology.

In The Last Decade

Jennifer Lin

40 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The VITamin D and OmegA-3 TriaL (VITAL): Rationale and design of a large randomized controlled trial of vitamin D and marine omega-3 fatty acid supplements for the primary prevention of cancer and cardiovascular disease

2011 387 citations JoAnn E. Manson, Shari S. Bassuk et al. Contemporary Clinical Trials profile →

Peers

Countries citing papers authored by Jennifer Lin

Since Specialization

Citations

This map shows the geographic impact of Jennifer Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jennifer Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jennifer Lin more than expected).

Fields of papers citing papers by Jennifer Lin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jennifer Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jennifer Lin. The network helps show where Jennifer Lin may publish in the future.

Co-authorship network of co-authors of Jennifer Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Jennifer Lin. A scholar is included among the top collaborators of Jennifer Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jennifer Lin. Jennifer Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Ibrutinib plus venetoclax in relapsed or refractory mantle cell lymphoma (SYMPATICO): a multicentre, randomised, double-blind, placebo-controlled, phase 3 study 2025 ·The Lancet Oncology ·Michael Wang, Wojciech Jurczak, Marek Trněný, David Belada, Tomasz Wróbel, Nilanjan Ghosh, Mary‐Margaret Keating, Tom van Meerten, (unknown), Gottfried von Keudell, Catherine Thiéblemont, Frédéric Peyrade, (unknown), Marc Hoffmann, Edith Szafer‐Glusman, Jennifer Lin, James P. Dean, Jutta K. Neuenburg, Constantine S. Tam	9
2	134 \| EFFICACY AND SAFETY OF FIRST‐LINE IBRUTINIB PLUS VENETOCLAX IN PATIENTS WITH MANTLE CELL LYMPHOMA (MCL) WHO WERE OLDER OR HAD TP53 MUTATIONS IN THE SYMPATICO STUDY 2025 ·Hematological Oncology ·M. Wang, Marc Hoffmann, Tomasz Wróbel, Marek Trněný, David Belada, Fatih Demırkan, Panayiotis Panayiotidis, (unknown), Pier Luigi Zinzani, Mary‐Margaret Keating, Sung‐Soo Yoon, (unknown), Constantine S. Tam, Nathalie A. Johnson, Edith Szafer‐Glusman, Jennifer Lin, James P. Dean, Jutta K. Neuenburg, Gottfried von Keudell	0
3	Efficacy and safety of ibrutinib plus venetoclax in patients with mantle cell lymphoma (MCL) and TP53 mutations in the SYMPATICO study. 2024 ·Journal of Clinical Oncology ·Michael Wang, Wojciech Jurczak, Marek Trněný, David Belada, Tomasz Wróbel, Nilanjan Ghosh, Mary‐Margaret Keating, Tom van Meerten, Rubén Fernández-Álvarez, Gottfried von Keudell, Catherine Thiéblemont, Frédéric Peyrade, (unknown), Marc Hoffmann, Maoko Naganuma, Edith Szafer‐Glusman, Jennifer Lin, James P. Dean, Jutta K. Neuenburg, Constantine S. Tam	4
4	Efficacy and Safety of Ibrutinib Plus Venetoclax in Patients With Mantle Cell Lymphoma (MCL) and TP53 Mutations in the SYMPATICO Study 2024 ·Clinical Lymphoma Myeloma & Leukemia ·Wojciech Jurczak, Michael Wang, Marek Trněný, David Belada, Tomasz Wróbel, Nilanjan Ghosh, Mary‐Margaret Keating, Tom van Meerten, (unknown), Gottfried von Keudell, Catherine Thiéblemont, Frédéric Peyrade, (unknown), Marc Hoffmann, Maoko Naganuma, Edith Szafer‐Glusman, Jennifer Lin, James P. Dean, Jutta K. Neuenburg, Constantine S. Tam	0
5	Ibrutinib Combined with Venetoclax in Patients with Relapsed/Refractory Mantle Cell Lymphoma: Primary Analysis Results from the Randomized Phase 3 Sympatico Study 2023 ·Blood ·Michael Wang, Wojciech Jurczak, Marek Trněný, David Belada, Tomasz Wróbel, Nilanjan Ghosh, Mary‐Margaret Keating, Tom van Meerten, (unknown), Gottfried von Keudell, Catherine Thiéblemont, Frédéric Peyrade, Marc André, Marc Hoffmann, (unknown), Jennifer Lin, James P. Dean, Jutta K. Neuenburg, Constantine S. Tam	13
6	The Omega-3 Index is higher in people from a coastal town versus 5 inland US cities: An observational study 2022 ·Nutrition Research ·William S. Harris, Nathan Tintle, (unknown), Jennifer Lin	3
7	Evaluating Targeted Next-Generation Sequencing Assays and Reference Materials for NTRK Fusion Detection 2021 ·Journal of Molecular Diagnostics ·(unknown), Jeeyun Lee, Marc Barritault, Pierre‐Paul Bringuier, Zhaolin Xu, Weei‐Yuarn Huang, (unknown), Joseph Castillo, Jason Christiansen, Jennifer Lin, Brandon S. Sheffield	17
8	Interferon γ–Induced Protein10 Kinetics in Treatment-Naive Versus Treatment-Experienced Patients Receiving Interferon-Free Therapy for Hepatitis C Virus Infection: Implications for the Innate Immune Response 2014 ·The Journal of Infectious Diseases ·Jennifer Lin, François Habersetzer, M. Rodríguez‐Torres, Nezam H. Afdhal, Eric Lawitz, Matthew Paulson, Yanni Zhu, G. Subramanian, John G. McHutchison, Mark Sulkowski, David Wyles, Robert T. Schooley	16
9	High incidence of serious adverse events in HIV-infected patients treated with a telaprevir-based hepatitis C virus treatment regimen 2013 ·AIDS ·Edward R. Cachay, David Wyles, Francesca J. Torriani, Craig Ballard, (unknown), Jennifer Lin, Lucas Hill, William C. Mathews	12
10	A Mammary Stem Cell Population Identified and Characterized in Late Embryogenesis Reveals Similarities to Human Breast Cancer 2012 ·Cell stem cell ·Benjamin T. Spike, Dannielle D. Engle, Jennifer Lin, Samantha K. Cheung, Justin La, Geoffrey M. Wahl	169
11	The use of ceftaroline fosamil in methicillin-resistant Staphylococcus aureus endocarditis and deep-seated MRSA infections: a retrospective case series of 10 patients 2012 ·Journal of Infection and Chemotherapy ·Jennifer Lin, (unknown), (unknown), Scott Johns, (unknown), Maximillian Jahng, (unknown), (unknown)	91
12	The VITamin D and OmegA-3 TriaL (VITAL): Rationale and design of a large randomized controlled trial of vitamin D and marine omega-3 fatty acid supplements for the primary prevention of cancer and cardiovascular disease breakdown → 2011 ·Contemporary Clinical Trials ·JoAnn E. Manson, Shari S. Bassuk, I‐Min Lee, Nancy R. Cook, Michelle A. Albert, David Gordon, Elaine Zaharris, Jean MacFadyen, Eleanor Danielson, Jennifer Lin, Shumin M. Zhang, Julie E. Buring	387
13	Skeletal muscle metastases: a three-part study of a not-so-rare entity 2011 ·Skeletal Radiology ·Tamara Miner Haygood, Jason Wong, Jennifer Lin, (unknown), Aurelio Matamoros, Colleen M. Costelloe, Henry Yeung, Carl M. Sandler, Rodolfo Núñez, Rajendra Kumar, John E. Madewell	39
14	Defining Intrahepatic Biliary Anatomy in Living Liver Transplant Donor Candidates at Mangafodipir Trisodium–enhanced MR Cholangiography versus Conventional T2-weighted MR Cholangiography 2004 ·Radiology ·Vivian S. Lee, Glenn A. Krinsky, (unknown), (unknown), James S. Babb, Jennifer Lin, Glyn Morgan, Lewis Teperman	58
15	Liver transplant donor candidates: Associations between vascular and biliary anatomic variants 2004 ·Liver Transplantation ·Vivian S. Lee, Glyn Morgan, Jennifer Lin, (unknown), (unknown), Lewis Teperman, Glenn A. Krinsky	47
16	Genome‐wide scan of brothers: Replication and fine mapping of prostate cancer susceptibility and aggressiveness loci 2003 ·The Prostate ·John S. Witte, Brian K. Suarez, Bonnie Thiel, Jennifer Lin, Adong Yu, Tarit K. Banerjee, James K. Burmester, Graham Casey, William J. Catàlona	42
17	Techniques and probes for the study of Xenopus tropicalis development 2002 ·Developmental Dynamics ·Mustafa K. Khokha, Christina Z. Chung, (unknown), (unknown), Kristin A. Trott, (unknown), Nancy Lim, Jennifer Lin, Nicola V. Taverner, Enrique Amaya, Nancy Papalopulu, James C. Smith, Aaron M. Zorn, Richard M. Harland, Timothy C. Grammer	195
18	Transcriptional regulatory effects of lymphoma-associated NFKB2/lyt10 protooncogenes 2000 ·Oncogene ·(unknown), Chunyan Gu, Sanjay Kumar Daulat Thakur, Eric Vieira, Jennifer Lin, Arnold B. Rabson	19
19	Chronic Creatine Kinase Elevation Not Associated with HMG-CoA Reductase Inhibitor Treatment 1999 ·Annals of Pharmacotherapy ·Jennifer Lin, Matthew K. Ito	3
20	QT Prolongation and Development of Torsades de Pointes with the Concomitant Administration of Oral Erythromycin Base and Quinidine 1997 ·Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy ·Jennifer Lin, (unknown)	25

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact